Quarterly Consolidated Statement Of Cash Flows

SAPPORO CLINICAL LABORATORY INC. - Filing #7247539

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
943,092,000 JPY
1,142,998,000 JPY
Interest and dividends received
6,561,000 JPY
5,549,000 JPY
Interest paid
-6,779,000 JPY
-7,399,000 JPY
Income taxes paid
-240,311,000 JPY
-201,775,000 JPY
Net cash provided by (used in) operating activities
730,911,000 JPY
1,077,593,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,222,168,000 JPY
-388,432,000 JPY
Proceeds from sale of property, plant and equipment
2,172,000 JPY
29,063,000 JPY
Purchase of investment securities
0 JPY
0 JPY
Other, net
31,019,000 JPY
20,581,000 JPY
Net cash provided by (used in) investing activities
-1,240,168,000 JPY
-395,474,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-135,367,000 JPY
-132,017,000 JPY
Purchase of treasury shares
-189,975,000 JPY
JPY
Dividends paid
-76,643,000 JPY
-76,531,000 JPY
Dividends paid to non-controlling interests
JPY
-32,000,000 JPY
Net cash provided by (used in) financing activities
-525,743,000 JPY
-369,961,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,034,999,000 JPY
312,157,000 JPY
Cash and cash equivalents
2,931,206,000 JPY
3,966,205,000 JPY
3,654,048,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.